List of works - Jose Luis Calleja-Panero

A randomized trial to compare the efficacy and tolerability of sodium picosulfate-magnesium citrate solution vs. 4 L polyethylene glycol solution as a bowel preparation for colonoscopy

scientific article published on 16 July 2015

Accuracy of portal and forearm blood flow measurements in the assessment of the portal pressure response to propranolol

scientific article published on 01 September 1997

Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy

scientific article published on 01 August 1997

Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under "Real-Life" Conditions.

scientific article

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B.

scientific article published in February 2006

Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.

scientific article published on 30 September 2015

Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial

scientific article published on 27 June 2009

Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.

scientific article published on 8 January 2013

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.

scientific article published on 10 March 2017

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

scientific article published on 15 December 2016

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

scientific article published on 8 February 2017

Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.

scientific article

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study.

scientific article published on 20 December 2016

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.

scientific article published on 27 December 2016

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

scientific article published on 13 March 2017

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

scientific article published on 31 January 2017

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia

scientific article published on 22 December 2015

Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

scientific article published on 23 September 2015

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

scientific article published on 30 April 2015

Gastric band cutter to remove a migrated gastric band

scientific article published on 06 March 2012

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

scientific article

HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment

scientific article

Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.

scientific article

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

scientific article published on May 2014

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

scientific article

Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study.

scientific article published on 29 July 2006

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

scientific article

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

scientific article published on March 1996

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

scientific article published on 06 June 2017

Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice

scientific article published on 11 May 2015

MASSIVE IMPACT OF COVID-19 PANDEMIC ON GASTROENTEROLOGY AND HEPATOLOGY DEPARTMENTS AND DOCTORS IN SPAIN

scientific article published on 12 November 2020

Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C ⬇️

scientific article published on April 14, 2013

Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation

scientific article published on 01 December 2008

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

scientific article published on 31 March 2015

Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation.

scientific article

Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.

scientific article published in June 2003

Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension

scientific article published on 01 July 1998

Randomised trial of fibrin glue versus polidocanol for bleeding peptic ulcer

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.

scientific article published on 12 September 2017

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents.

scientific article

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

scientific article

Reply

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

scientific article published on 14 May 2015

Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension.

scientific article

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

scientific article

Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

scientific article published on 29 November 2016

Strategies to manage hepatitis C virus (HCV) disease burden.

scientific article published on May 2014

Successful Continuation of HCV Treatment After Liver Transplantation

scientific article published on December 2016

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis

scientific article published on 2 October 2014

The efficiency of several one-step testing strategies for the diagnosis of hepatitis C

scientific article published on 01 January 2019

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

scientific article published on May 2014

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

scientific article

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.

scientific article published on 14 October 2014

Validation of non invasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.

scientific article

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

scientific article published on November 1990

List of works by Jose Luis Calleja-Panero

A randomized trial to compare the efficacy and tolerability of sodium picosulfate-magnesium citrate solution vs. 4 L polyethylene glycol solution as a bowel preparation for colonoscopy

Accuracy of portal and forearm blood flow measurements in the assessment of the portal pressure response to propranolol

Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy

Cost-Effectiveness Analysis Of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment Of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under "Real-Life" Conditions.

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B.

Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.

Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial

Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial.

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.

Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study.

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia

Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

Gastric band cutter to remove a migrated gastric band

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment

Helicobacter pylori infection in patients with erosive esophagitis is associated with rapid heartburn relief and lack of relapse after treatment with pantoprazole.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study.

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice

MASSIVE IMPACT OF COVID-19 PANDEMIC ON GASTROENTEROLOGY AND HEPATOLOGY DEPARTMENTS AND DOCTORS IN SPAIN

Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C ⬇️

Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation.

Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT.

Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension

Randomised trial of fibrin glue versus polidocanol for bleeding peptic ulcer

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.

Reactivation of Herpesvirus in Patients With Hepatitis C Treated With Direct-Acting Antiviral Agents.

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

Reply

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

Selective impairment of endothelium-mediated vasodilation in liver transplant recipients with cyclosporin A-induced hypertension.

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

Strategies to manage hepatitis C virus (HCV) disease burden.

Successful Continuation of HCV Treatment After Liver Transplantation

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis

The efficiency of several one-step testing strategies for the diagnosis of hepatitis C

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.

Validation of non invasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease.

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.